CVRx, Inc. Proceeds from Other Equity
CVRx, Inc. (CVRX) reported Proceeds from Other Equity of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2022-02-22
- CVRx, Inc. proceeds from other equity for the quarter ending 2021-12-31 was $0.00.
- CVRx, Inc. proceeds from other equity for the quarter ending 2020-12-31 was $0.00.
- CVRx, Inc. proceeds from other equity for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CVRx, Inc. proceeds from other equity for fiscal 2020 was $49.78M.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 10-K · filed 2022-02-22 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $49.78M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $49.78M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |